Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines.

Hioe CE, Kumar R, Upadhyay C, Jan M, Fox A, Itri V, Peachman KK, Rao M, Liu L, Lo NC, Tuen M, Jiang X, Kong XP, Zolla-Pazner S.

Front Immunol. 2018 Oct 26;9:2441. doi: 10.3389/fimmu.2018.02441. eCollection 2018.

2.

Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans.

Rao M, Onkar S, Peachman KK, White Y, Trinh HV, Jobe O, Zhou Y, Dawson P, Eller MA, Matyas GR, Alving CR.

J Infect Dis. 2018 Oct 5;218(10):1541-1550. doi: 10.1093/infdis/jiy348.

PMID:
29893872
3.

Isolation of human lymphocytes with high yield and viability from the gastrointestinal and female reproductive tract of a humanized DRAG mouse.

Allam A, Peachman KK, Aguilera-Olvera R, Casares S, Rao M.

J Immunol Methods. 2018 Mar;454:40-47. doi: 10.1016/j.jim.2017.12.004. Epub 2017 Dec 24.

PMID:
29278684
4.

Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant.

Torres OB, Matyas GR, Rao M, Peachman KK, Jalah R, Beck Z, Michael NL, Rice KC, Jacobson AE, Alving CR.

NPJ Vaccines. 2017 May 2;2:13. doi: 10.1038/s41541-017-0013-9. eCollection 2017.

5.

Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model.

Kim J, Peachman KK, Jobe O, Morrison EB, Allam A, Jagodzinski L, Casares SA, Rao M.

Front Immunol. 2017 Oct 27;8:1405. doi: 10.3389/fimmu.2017.01405. eCollection 2017.

6.

Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.

Kijak GH, Sanders-Buell E, Chenine AL, Eller MA, Goonetilleke N, Thomas R, Leviyang S, Harbolick EA, Bose M, Pham P, Oropeza C, Poltavee K, O'Sullivan AM, Billings E, Merbah M, Costanzo MC, Warren JA, Slike B, Li H, Peachman KK, Fischer W, Gao F, Cicala C, Arthos J, Eller LA, O'Connell RJ, Sinei S, Maganga L, Kibuuka H, Nitayaphan S, Rao M, Marovich MA, Krebs SJ, Rolland M, Korber BT, Shaw GM, Michael NL, Robb ML, Tovanabutra S, Kim JH.

PLoS Pathog. 2017 Sep 14;13(9):e1006620. doi: 10.1371/journal.ppat.1006620. eCollection 2017 Sep.

7.

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.

Kijak GH, Sanders-Buell E, Chenine AL, Eller MA, Goonetilleke N, Thomas R, Leviyang S, Harbolick EA, Bose M, Pham P, Oropeza C, Poltavee K, O'Sullivan AM, Billings E, Merbah M, Costanzo MC, Warren JA, Slike B, Li H, Peachman KK, Fischer W, Gao F, Cicala C, Arthos J, Eller LA, O'Connell RJ, Sinei S, Maganga L, Kibuuka H, Nitayaphan S, Rao M, Marovich MA, Krebs SJ, Rolland M, Korber BT, Shaw GM, Michael NL, Robb ML, Tovanabutra S, Kim JH.

PLoS Pathog. 2017 Jul 31;13(7):e1006510. doi: 10.1371/journal.ppat.1006510. eCollection 2017 Jul. Erratum in: PLoS Pathog. 2017 Sep 14;13(9):e1006620.

8.

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

Bradley T, Pollara J, Santra S, Vandergrift N, Pittala S, Bailey-Kellogg C, Shen X, Parks R, Goodman D, Eaton A, Balachandran H, Mach LV, Saunders KO, Weiner JA, Scearce R, Sutherland LL, Phogat S, Tartaglia J, Reed SG, Hu SL, Theis JF, Pinter A, Montefiori DC, Kepler TB, Peachman KK, Rao M, Michael NL, Suscovich TJ, Alter G, Ackerman ME, Moody MA, Liao HX, Tomaras G, Ferrari G, Korber BT, Haynes BF.

Nat Commun. 2017 Jun 8;8:15711. doi: 10.1038/ncomms15711.

9.

Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin.

Chand S, Messina EL, AlSalmi W, Ananthaswamy N, Gao G, Uritskiy G, Padilla-Sanchez V, Mahalingam M, Peachman KK, Robb ML, Rao M, Rao VB.

Virology. 2017 Aug;508:199-212. doi: 10.1016/j.virol.2017.05.016. Epub 2017 May 31.

10.

Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies.

Kim J, Jobe O, Peachman KK, Michael NL, Robb ML, Rao M, Rao VB.

Virology. 2017 Aug;508:188-198. doi: 10.1016/j.virol.2017.05.015. Epub 2017 May 31.

11.

Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region.

Jobe O, Trinh HV, Kim J, Alsalmi W, Tovanabutra S, Ehrenberg PK, Peachman KK, Gao G, Thomas R, Kim JH, Michael NL, Alving CR, Rao VB, Rao M.

J Leukoc Biol. 2016 Jun;99(6):1089-106. doi: 10.1189/jlb.2A0815-361R. Epub 2015 Dec 14.

12.

Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.

Peachman KK, Karasavvas N, Chenine AL, McLinden R, Rerks-Ngarm S, Jaranit K, Nitayaphan S, Pitisuttithum P, Tovanabutra S, Zolla-Pazner S, Michael NL, Kim JH, Alving CR, Rao M.

PLoS One. 2015 Dec 1;10(12):e0143895. doi: 10.1371/journal.pone.0143895. eCollection 2015.

13.

Isolation and purification of proteasomes from primary cells.

Steers NJ, Peachman KK, Alving CR, Rao M.

Curr Protoc Immunol. 2014 Nov 3;107:16.4.1-20. doi: 10.1002/0471142735.im1604s107. Review.

PMID:
25367127
14.

HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development.

Rao M, Peachman KK, Kim J, Gao G, Alving CR, Michael NL, Rao VB.

Curr HIV Res. 2013 Jul;11(5):427-38.

15.

Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2.

Liao HX, Bonsignori M, Alam SM, McLellan JS, Tomaras GD, Moody MA, Kozink DM, Hwang KK, Chen X, Tsao CY, Liu P, Lu X, Parks RJ, Montefiori DC, Ferrari G, Pollara J, Rao M, Peachman KK, Santra S, Letvin NL, Karasavvas N, Yang ZY, Dai K, Pancera M, Gorman J, Wiehe K, Nicely NI, Rerks-Ngarm S, Nitayaphan S, Kaewkungwal J, Pitisuttithum P, Tartaglia J, Sinangil F, Kim JH, Michael NL, Kepler TB, Kwong PD, Mascola JR, Nabel GJ, Pinter A, Zolla-Pazner S, Haynes BF.

Immunity. 2013 Jan 24;38(1):176-86. doi: 10.1016/j.immuni.2012.11.011. Epub 2013 Jan 11.

16.

Designing a soluble near full-length HIV-1 gp41 trimer.

Gao G, Wieczorek L, Peachman KK, Polonis VR, Alving CR, Rao M, Rao VB.

J Biol Chem. 2013 Jan 4;288(1):234-46. doi: 10.1074/jbc.M112.424432. Epub 2012 Nov 26.

17.

An anti-phosphoinositide-specific monoclonal antibody that neutralizes HIV-1 infection of human monocyte-derived macrophages.

Jobe O, Peachman KK, Matyas GR, Asher LV, Alving CR, Rao M.

Virology. 2012 Sep 1;430(2):110-9. doi: 10.1016/j.virol.2012.04.017. Epub 2012 May 26.

18.

Adjuvants for human vaccines.

Alving CR, Peachman KK, Rao M, Reed SG.

Curr Opin Immunol. 2012 Jun;24(3):310-5. doi: 10.1016/j.coi.2012.03.008. Epub 2012 Apr 19. Review.

19.

Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores.

Peachman KK, Li Q, Matyas GR, Shivachandra SB, Lovchik J, Lyons RC, Alving CR, Rao VB, Rao M.

Clin Vaccine Immunol. 2012 Jan;19(1):11-6. doi: 10.1128/CVI.05376-11. Epub 2011 Nov 16.

20.

Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation.

Alving CR, Rao M, Peachman KK, Asher L, Rao VB.

J Liposome Res. 2011 Dec;21(4):279-85. doi: 10.3109/08982104.2011.559646. Epub 2011 Mar 14.

PMID:
21401373
21.

The importance of antibody isotype in HIV-1 virus capture assay and in TZM-bl neutralization.

Peachman KK, Wieczorek L, Matyas GR, Polonis VR, Alving CR, Rao M.

Viral Immunol. 2010 Dec;23(6):627-32. doi: 10.1089/vim.2010.0061.

PMID:
21142448
22.

Highly effective generic adjuvant systems for orphan or poverty-related vaccines.

Rao M, Peachman KK, Li Q, Matyas GR, Shivachandra SB, Borschel R, Morthole VI, Fernandez-Prada C, Alving CR, Rao VB.

Vaccine. 2011 Jan 29;29(5):873-7. doi: 10.1016/j.vaccine.2010.11.049. Epub 2010 Nov 27.

23.

The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies.

Peachman KK, Wieczorek L, Polonis VR, Alving CR, Rao M.

Virology. 2010 Dec 20;408(2):213-23. doi: 10.1016/j.virol.2010.09.029. Epub 2010 Oct 20.

24.

Human erythrocytes selectively bind and enrich infectious HIV-1 virions.

Beck Z, Brown BK, Wieczorek L, Peachman KK, Matyas GR, Polonis VR, Rao M, Alving CR.

PLoS One. 2009 Dec 14;4(12):e8297. doi: 10.1371/journal.pone.0008297.

25.

Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines.

Steers NJ, Peachman KK, McClain S, Alving CR, Rao M.

Vaccine. 2009 Nov 16;27(49):6939-49. doi: 10.1016/j.vaccine.2009.08.105. Epub 2009 Sep 11.

PMID:
19748578
26.

Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.

Steers NJ, Peachman KK, McClain SR, Alving CR, Rao M.

J Virol. 2009 Jul;83(14):7049-61. doi: 10.1128/JVI.00327-09. Epub 2009 Apr 29.

27.

Dengue virus infection promotes translocation of high mobility group box 1 protein from the nucleus to the cytosol in dendritic cells, upregulates cytokine production and modulates virus replication.

Kamau E, Takhampunya R, Li T, Kelly E, Peachman KK, Lynch JA, Sun P, Palmer DR.

J Gen Virol. 2009 Aug;90(Pt 8):1827-35. doi: 10.1099/vir.0.009027-0. Epub 2009 Apr 15.

PMID:
19369409
28.

Regulation of arachidonate remodeling enzymes impacts eosinophil survival during allergic asthma.

Seeds MC, Peachman KK, Bowton DL, Sivertson KL, Chilton FH.

Am J Respir Cell Mol Biol. 2009 Sep;41(3):358-66. doi: 10.1165/rcmb.2008-0192OC. Epub 2009 Jan 16.

29.

Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits.

Li Q, Peachman KK, Sower L, Leppla SH, Shivachandra SB, Matyas GR, Peterson JW, Alving CR, Rao M, Rao VB.

Open Vaccine J. 2009;2:92-99.

30.

The differential effect of dexamethasone on granulocyte apoptosis involves stabilization of Mcl-1L in neutrophils but not in eosinophils.

Sivertson KL, Seeds MC, Long DL, Peachman KK, Bass DA.

Cell Immunol. 2007 Mar;246(1):34-45. Epub 2007 Jun 14.

31.

Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells.

Palmer DR, Fernandez S, Bisbing J, Peachman KK, Rao M, Barvir D, Gunther V, Burgess T, Kohno Y, Padmanabhan R, Sun W.

J Gen Virol. 2007 Jan;88(Pt 1):148-56.

PMID:
17170447
32.

Multicomponent anthrax toxin display and delivery using bacteriophage T4.

Shivachandra SB, Li Q, Peachman KK, Matyas GR, Leppla SH, Alving CR, Rao M, Rao VB.

Vaccine. 2007 Jan 26;25(7):1225-35. Epub 2006 Oct 17.

34.

Human dendritic cells and macrophages exhibit different intracellular processing pathways for soluble and liposome-encapsulated antigens.

Peachman KK, Rao M, Alving CR, Palmer DR, Sun W, Rothwell SW.

Immunobiology. 2005;210(5):321-33.

PMID:
16164039
35.

Functional microtubules are required for antigen processing by macrophages and dendritic cells.

Peachman KK, Rao M, Palmer DR, Zidanic M, Sun W, Alving CR, Rothwell SW.

Immunol Lett. 2004 Aug 15;95(1):13-24.

PMID:
15325793
36.

Modulation of dengue virus infection of dendritic cells by Aedes aegypti saliva.

Ader DB, Celluzzi C, Bisbing J, Gilmore L, Gunther V, Peachman KK, Rao M, Barvir D, Sun W, Palmer DR.

Viral Immunol. 2004;17(2):252-65.

PMID:
15279703
37.

Depletion of cellular cholesterol interferes with intracellular trafficking of liposome-encapsulated ovalbumin.

Rao M, Peachman KK, Alving CR, Rothwell SW.

Immunol Cell Biol. 2003 Dec;81(6):415-23. Review.

PMID:
14636238
38.

Immunization with DNA through the skin.

Peachman KK, Rao M, Alving CR.

Methods. 2003 Nov;31(3):232-42. Review.

PMID:
14511956
39.

Mitochondria in eosinophils: functional role in apoptosis but not respiration.

Peachman KK, Lyles DS, Bass DA.

Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1717-22.

Supplemental Content

Loading ...
Support Center